Results for the Third Quarter 2015

Sales ended at MNOK 61.6 for the quarter (MNOK 52.0), an 18.5 % growth. Sales as of September increased by 18.9 % and ended at MOK 176.8 (MNOK 148.7). Operating profit (EBIT) for the quarter…

Read more

Medistim Launches the MiraQ™ Vascular System

Medistim launches the newest product on the MiraQ™ quality assessment platform - The MiraQ™ Vascular System- specifically for vascular surgery. The system is introduced for the first time at the ESVS annual meeting in Porto,…

Read more

Results for the First Quarter 2015

Sales for the quarter ended at MNOK 57.9 (MNOK 48.9), an increase of 18.5 %. Operating profit (EBIT) ended at MNOK 9.9 (MNOK 7.2), up 36.7 %. There was a strong development in sales in…

Read more

Medistim Delivers Best Quarter Ever

Medistim delivers its best quarter ever and sales ended at MNOK 66.1 (MNOK 52.2), a growth of 26.6 %. Sales for 2014 ended at MNOK 214.8 (MNOK 191.0), a growth of 12.5 %. The atrong…

Read more